Resources
ÐÜèÊÓÆµComment Letter on Interchangeable Biosimilar Applications
Comment Letter
ÐÜèÊÓÆµsubmitted comments to FDA Commissioner Robert M. Califf, M.D., regarding interchangeable biosimilar applications.
Document Info
Published on Aug 20, 2024
Download and read the full Resource.